DekaBank Deutsche Girozentrale Trims Stake in DocuSign, Inc. (NASDAQ:DOCU)

DekaBank Deutsche Girozentrale cut its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 26.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 35,560 shares of the company's stock after selling 13,115 shares during the period. DekaBank Deutsche Girozentrale's holdings in DocuSign were worth $2,176,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Massmutual Trust Co. FSB ADV lifted its stake in shares of DocuSign by 5,000.0% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company's stock worth $27,000 after purchasing an additional 500 shares during the period. Mather Group LLC. raised its position in DocuSign by 4,338.5% in the second quarter. Mather Group LLC. now owns 577 shares of the company's stock worth $31,000 after acquiring an additional 564 shares during the period. nVerses Capital LLC purchased a new position in shares of DocuSign during the 2nd quarter worth $48,000. Quarry LP bought a new stake in shares of DocuSign during the 2nd quarter valued at $53,000. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of DocuSign in the 2nd quarter worth $72,000. 77.64% of the stock is owned by institutional investors.

DocuSign Trading Up 2.5 %

DOCU traded up $1.73 during trading on Friday, hitting $71.11. 2,594,606 shares of the company traded hands, compared to its average volume of 2,908,471. The company has a market cap of $14.43 billion, a PE ratio of 15.00, a P/E/G ratio of 7.30 and a beta of 0.90. The stock's 50-day simple moving average is $63.16 and its two-hundred day simple moving average is $58.04. DocuSign, Inc. has a 1 year low of $39.21 and a 1 year high of $73.80.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.80 by $0.17. The firm had revenue of $736.03 million during the quarter, compared to analyst estimates of $727.20 million. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. During the same quarter last year, the business posted $0.09 earnings per share. The business's quarterly revenue was up 7.0% compared to the same quarter last year. Equities analysts expect that DocuSign, Inc. will post 1.01 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on DOCU shares. Wells Fargo & Company lifted their target price on DocuSign from $48.00 to $50.00 and gave the company an "underweight" rating in a research report on Friday, September 6th. JMP Securities reiterated a "market outperform" rating and set a $84.00 price objective on shares of DocuSign in a research note on Thursday, September 5th. Bank of America increased their target price on shares of DocuSign from $60.00 to $68.00 and gave the stock a "neutral" rating in a report on Friday, September 6th. Robert W. Baird lifted their price target on shares of DocuSign from $55.00 to $59.00 and gave the company a "neutral" rating in a report on Friday, September 6th. Finally, Needham & Company LLC reissued a "hold" rating on shares of DocuSign in a research note on Friday, September 6th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, DocuSign presently has an average rating of "Hold" and an average target price of $63.40.

Insider Transactions at DocuSign

In other DocuSign news, Director Teresa Briggs sold 534 shares of the stock in a transaction on Monday, September 16th. The shares were sold at an average price of $56.56, for a total transaction of $30,203.04. Following the completion of the transaction, the director now owns 7,202 shares in the company, valued at $407,345.12. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other DocuSign news, Director Teresa Briggs sold 534 shares of the business's stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $56.56, for a total transaction of $30,203.04. Following the sale, the director now directly owns 7,202 shares of the company's stock, valued at $407,345.12. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Allan C. Thygesen sold 7,725 shares of the company's stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $59.09, for a total value of $456,470.25. Following the sale, the chief executive officer now owns 102,193 shares in the company, valued at approximately $6,038,584.37. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 132,777 shares of company stock valued at $7,267,469 in the last ninety days. Corporate insiders own 1.66% of the company's stock.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.